A novel variant in CYFIP2 in a girl with severe disabilities and bilateral perisylvian polymicrogyria

dc.contributor.authorSalokivi Tommi
dc.contributor.authorParkkola Riitta
dc.contributor.authorRajendran Yasmin
dc.contributor.authorBharadwaj Thashi
dc.contributor.authorAcharya Anushree
dc.contributor.authorLeal Suzanne M.
dc.contributor.authorJärvelä Irma
dc.contributor.authorArvio Maria
dc.contributor.authorSchrauwen Isabelle
dc.contributor.organizationfi=kuvantaminen ja kliininen diagnostiikka|en=Imaging and Clinical Diagnostics|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organizationfi=yleislääketiede|en=General Practice|
dc.contributor.organization-code1.2.246.10.2458963.20.21889691131
dc.contributor.organization-code1.2.246.10.2458963.20.69079168212
dc.contributor.organization-code2607328
dc.converis.publication-id182384787
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/182384787
dc.date.accessioned2025-08-28T03:30:25Z
dc.date.available2025-08-28T03:30:25Z
dc.description.abstract<p>Bilateral perisylvian polymicrogyria (BPP) is a structural malformation of the cerebral cortex that can be caused by several genetic abnormalities. The most common clinical manifestations of BPP include intellectual disability and epilepsy. Cytoplasmic FMRP-interacting protein 2 (CYFIP2) is a protein that interacts with the fragile X mental retardation protein (FMRP). <em>CYFIP2</em> variants can cause various brain structural abnormalities with the most common clinical manifestations of intellectual disability, epileptic encephalopathy and dysmorphic features. We present a girl with multiple disabilities and BPP caused by a heterozygous, novel, likely pathogenic variant (c.1651G>C: p.(Val551Leu) in the <em>CYFIP2</em> gene. Our case report broadens the spectrum of genetic diversity associated with BPP by incorporating <em>CYFIP2</em>.<br></p>
dc.identifier.eissn1552-4833
dc.identifier.jour-issn1552-4825
dc.identifier.olddbid210746
dc.identifier.oldhandle10024/193773
dc.identifier.urihttps://www.utupub.fi/handle/11111/55688
dc.identifier.urlhttp://dx.doi.org/10.1002%2Fajmg.a.63478
dc.identifier.urnURN:NBN:fi-fe2025082788715
dc.language.isoen
dc.okm.affiliatedauthorSalokivi, Tommi
dc.okm.affiliatedauthorParkkola, Riitta
dc.okm.affiliatedauthorArvio, Maria
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline318 Medical biotechnologyen_GB
dc.okm.discipline318 Lääketieteen bioteknologiafi_FI
dc.okm.internationalcopublicationinternational co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherWiley
dc.publisher.countryUnited Statesen_GB
dc.publisher.countryYhdysvallat (USA)fi_FI
dc.publisher.country-codeUS
dc.relation.doi10.1002/ajmg.a.63478
dc.relation.ispartofjournalAmerican Journal of Medical Genetics Part A
dc.source.identifierhttps://www.utupub.fi/handle/10024/193773
dc.titleA novel variant in CYFIP2 in a girl with severe disabilities and bilateral perisylvian polymicrogyria
dc.year.issued2023

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
SalokiviEtal2023ANovelVariantInCYFIP2.pdf
Size:
182.23 KB
Format:
Adobe Portable Document Format